Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA Animal Free,Azide Free,Carrier Free,ExactAb™,Low Endotoxin,Recombinant,Validated for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -80°C,Avoid repeated freezing and thawing Ships Dry ice packs + Cold packs Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
Nimotuzumab (anti-EGFR) is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab (anti-EGFR) is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab (anti-EGFR), a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC)[1][2].
Nimotuzumab (anti-EGFR) (Ab175612) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Nimotuzumab (anti-EGFR) (Ab175612). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nimotuzumab (anti-EGFR) (Ab175612) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling EGFR (red) with Nimotuzumab (anti-EGFR) (Ab175612). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nimotuzumab (anti-EGFR) (Ab175612) - SEC
The purity of Nimotuzumab (anti-EGFR) (Ab175612) is more than 95% verified by HPLC.
Nimotuzumab (anti-EGFR) (Ab175612) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Nimotuzumab (anti-EGFR) (Ab175612) with the EC50 of 45.18 ng/mL.
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ26F0333701 | Certificate of Analysis | Mar 31, 2026 | Ab175612 |
| ZJ26F0333700 | Certificate of Analysis | Mar 31, 2026 | Ab175612 |
| ZJ26F0333699 | Certificate of Analysis | Mar 31, 2026 | Ab175612 |
| ZJ24F0403995 | Certificate of Analysis | Apr 01, 2024 | Ab175612 |
| ZJ24F0403994 | Certificate of Analysis | Apr 01, 2024 | Ab175612 |
| ZJ24F0403993 | Certificate of Analysis | Apr 01, 2024 | Ab175612 |
Our grade selection guide covers purity, stabilizer status, and application suitability for all variants in our catalog.
View Animal Free grade guide → View Carrier Free grade guide → View Recombinant grade guide → View Validated grade guide → View ExactAb™ grade guide → View Low Endotoxin grade guide → View Azide Free grade guide →
